Overview
Sheng Lei practices practicing medicine in Nanjing, China.
Her clinical expertise encompasses Beta-Propeller Protein-Associated Neurodegeneration.
She is actively involved in clinical research, co-authoring 26 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sheng Lei
Is Sheng Lei a top-rated expert for Beta-Propeller Protein-Associated Neurodegeneration?
MediFind is an objective health platform that identifies experts based on real-world data. Sheng Lei is classified as an Experienced expert for Beta-Propeller Protein-Associated Neurodegeneration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sheng Lei participate in research or clinical trials?
Yes. Sheng Lei has published 26 articles and abstracts on conditions like Beta-Propeller Protein-Associated Neurodegeneration. You can view a list of Sheng Lei's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Beta-Propeller Protein-Associated Neurodegeneration